Evidence map›Paper›PMID 42793688›Full record

ReviewDiagnostics (Basel, Switzerland)2026

Molecular Classification of Endometrial Cancer in the Era of Precision Oncology: Prognostic Significance, Emerging Biomarkers, and Personalized Therapeutic Strategies-A Systematic Review.

Gulinur Chinaliyeva, Azat Chinaliyev, Zhanna Amirbekova, Amankeldi Salybekov, Aida Shakirova, Didar Khassenov, Zhandos Burkitbayev, Nino Dznelashvili

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gulinur ChinaliyevaDepartment of Doctoral Studies, Karaganda Medical University, Karaganda 100008, Kazakhstan.ORCID 0009-0003-9958-2484
Azat ChinaliyevNational Research Oncology Center, Astana 010000, Kazakhstan.ORCID 0000-0002-7142-6194
Zhanna AmirbekovaDepartment of Obstetrics, Gynecology and Perinatology, Karaganda Medical University, Karaganda 100008, Kazakhstan.
Amankeldi SalybekovQazaq Institute of Innovative Medicine, Astana 020000, Kazakhstan.ORCID 0000-0001-5490-9365
Aida ShakirovaWomen's Health Department, National Research Oncology Center, Astana 010000, Kazakhstan.
Didar KhassenovNational Research Oncology Center, Astana 010000, Kazakhstan.ORCID 0009-0004-0292-460X
Zhandos BurkitbayevNational Research Oncology Center, Astana 010000, Kazakhstan.
Nino DznelashviliHealthycore Israel-Georgian Multi-Profile Clinic, Tbilisi 0112, Georgia.ORCID 0009-0003-5429-7938

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersendometrial cancermicrosatellite instabilitymismatch repair deficiencymolecular classificationmultiple-classifier tumorsNSMPp53 immunohistochemistryPOLEprecision oncologyProMisETCGA

Identifiers

PMID42793688
PMCPMC13605146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.